Autoantibody Diversity Is Augmented in Women with Breast Cancer and Is Related to the Stage of the Disease
Breast cancer (BC) is the most frequent malignant neoplasia and leading cause of cancer mortality for women. A timely diagnosis of BC is crucial to ensure the best chances of survival. Among the various screening tools for BC, antibodies directed towards self-antigens or tumor-associated antigens (a...
Main Authors: | Jesús Pérez-Hernández, Rosalba León-Díaz, Alejandro Zentella, Edmundo Lamoyi, Marcela Esquivel-Velázquez, Antonia Barranca-Enríquez, Tania Romo-González |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/10/634 |
Similar Items
-
The Predictive Value of Autoantibodies in Determining Autoimmune Hepatitis (AIH) Severity
by: Iraj Shahramian, et al.
Published: (2023-06-01) -
Following Natural Autoantibodies: Further Immunoserological Evidence Regarding Their Silent Plasticity and Engagement in Immune Activation
by: David Szinger, et al.
Published: (2023-10-01) -
Psychological suppressive profile and autoantibodies variability in women living with breast cancer: A prospective cross-sectional study
by: Tania Romo-González, et al.
Published: (2022-10-01) -
Autoantibody and Viral Serologic Examinations in Multiple Sclerosis and Stroke
by: Beuy Joob, et al.
Published: (2020-12-01) -
Autoantibodies research progress /
by: Dubois, Quentin P.
Published: (2008)